Bangalore S.,Kamalakkannan G Fau - Parkar S.,Parkar S Fau - Messerli F. H.,Messerli F. H. .2007 .Fixed-dose combinations improve medication compliance: a metaanalysis. Am J Med, 120 : 713-719.
.2005 .. , 116 : 117.
United States Pharmacopeial Convention .2015 .. , : .
Stumpe K. O. .2004 .Olmesartan compared with other angiotensin II receptor antagonists: head-to-head trials. Clinical Therapeutics, 26 : 33-37.
United States Pharmacopeial Convention .2015 .. , : .
Carter B. L.,Ernst M. E.,Cohen J. D.,Hydrochlorothiazide Versus J. D.,E J. D. .2004 .Chlorthalidone. Hypertension, 0000103632 : 4-9.
United States Pharmacopeial Convention .2015 .. , : .
Li Y. R. .2015 .CardiovasCular diseases: From Molecular Pharmacology to evidence‐Based Therapeutics. , 189 : .
Sheikh M.,Annadi A.,Mohamed A. .2018 .A Novel RP-HPLC Method for the Simultaneous Assessment of Olmesartan, Amlodipine and Hydrochlorothiazide and its Application to Invitro Dissolution. Der Pharma Chemica, 10 : 55-61.
Jain P.,Patel M. K.,Gorle A. P.,Chaudhari A.,Surana S. .2012 .Stability-Indicating Method for Simultaneous Estimation of Olmesartan Medoxomile, Amlodipine Besylate and Hydrochlorothiazide by RP-HPLC in Tablet Dosage Form. Journal of chromatographic science 50, : 680-687.
Qutab S.,Razzaq D. S. N.,Ashfaq M.,Khan I.,Mumtaz A. M. .2009 .Simultaneous quantitation of Olmesartan Medoxomil and Amlodipine Besylate in combined tablets using HPLC. Journal of the Chilean Chemical Society, 54 : 234-237.
Kumar D.,Panda S.,Sahoo S. .2019 .Development of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Amlodipine and Olmesartan in Pure and Pharmaceutical Dosage Form. International Journal of Pharmaceutical Quality Assurance, 10(4) : .
Manoharan G.,Al-Bratty M.,Alhazmi H. Development .2016 .and validation of reversedphase HPLC techniques for simultaneous estimation of amlodipine, hydrochlorothiazide and olmesartan in raw and tablet formulation. International Journal of Pharmaceutical Sciences Review and Research, 38 : 205-209.
Pandya G.,Joshi H. Development .2013 .and validation of stability indicating HPLC assay method for simultaneous determination of Amlodepine besylate, olmesartan medoxomil and hydrochlorothiazide in tablet formulation. Der Phamacia Sinica, 4 : .
Napoleon A.,Angajala G.,A G.,R. G. .2015 .HPLC method development and validation for simultaneous estimation of Olmesartan Medoxomil, Hydrochlorothiazide and Amlodipine Besylate tablets. Der Pharmacia Lettre, 7 : 182-196.
Patchala A.,Nadendla R. .2020 .Quantification and validation of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide by rp-hplc in marketed dosage form. International Journal of Pharmaceutical Sciences and Research, 11 : 2350-2355.
Moffat A. C. .2011 .Clarke's Analysis of Drugs and Poisons. 4th edn, : .
Dolan ,North America .2003 .. , 10(LCGC) : 968-972.
.2005 .(International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. , : .
Ferreira S. L. C.,Caires A. O.,Fau - Borges S.,Borges T. da S.,Fau - Lima A. M. D. S.,Lima A. M. D. S. Fau - Silva L. O. B.,Silva L. O. B. Fau - dos Santos W. N. L.,dos Santos W. N. L. .2017 .Robustness evaluation in analytical methods optimized using experimental designs. Microchem J, 131 : 163-169.
Heyden Vander,Nijhuis Y.,SmeyersVerbeke J Fau - Vandeginste A Fau.,Massart B. G. M. .2001 .Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed Anal, 24 : 723-753.